CJC1295 w/DAC
CJC-1295 with DAC is a synthetic modified GHRH analog incorporating a Drug Affinity Complex (DAC) — a maleimidoproprionic acid group — enabling covalent albumin binding that significantly extends receptor interaction duration in laboratory settings. Supplied as a lyophilized powder in a 3mL vial, it is intended exclusively for in vitro laboratory research by qualified scientific personnel.
This peptide has been utilized in preclinical studies examining sustained GHRH receptor binding kinetics, albumin interaction dynamics, prolonged pituitary somatotroph cell signaling, and extended GH axis pathway activity in controlled cell models — independent of the broader endocrine effects associated with endogenous GHRH activity.
Product Details
- Form: Lyophilized powder (for laboratory research)
- Amount: 2 mg or 5 mg per vial (common research sizes)
- Purity: ≥ 98% (HPLC tested)
- Sequence: Modified GHRH (30 amino acids with DAC linker)
- Molecular Formula: C₁₆₅H₂₇₁N₄₇O₄₆
- Molecular Weight: ~3649 Da
- Intended Use: Laboratory research only
DISCLAIMER: This product is strictly to be used for scientific research use only. It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes.
We recommend you review our Terms of Service if you have questions about product use.
